Sponsor:
Duke University
Code:
NCT06972719
Conditions
BRCA1 Mutation
BRCA2 Mutation
Eligibility Criteria
Sex: Female
Age: 19 - 50
Healthy Volunteers: Not accepted
Interventions
Experimental Arm
SOC Arm
Brief summary:
Conditions
BRCA1 Mutation
BRCA2 Mutation
Study ID
NCT06972719
Start date
Sep 30, 2025
Status verified date
Aug, 2026
Completion date
Jun 30, 2027
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: Female
Age: 19 - 50
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
placebo comparator: Standard of Care
experimental: Experimental
Interventions
Experimental Arm
SOC Arm
Primary outcome measure
Central contacts
Locations
UNC Chapel Hill Health System
Recruiting
Chapel Hill, North Carolina, United States, 27514
Contacts
Principal Investigator:
Katherine Tucker, MD
Duke University Health System
Recruiting
Durham, North Carolina, United States, 27710
Contacts
Principal Investigator:
Laura Havrilesky, MD
Sponsor
Duke University
Last update posted
Aug 4, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Duke University on 2026-08-04.